Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing

Fig. 2

Reductions in total average SARS-CoV-2 transmission risk after infection at a known high-risk exposure time (day 0) without considering travel. Transmission risk reductions are stratified by method of risk reduction including symptom monitoring, quarantine (7 or 14 days), and testing (test on days 1–7). Symptom monitoring is assumed to be ongoing regardless of the test date when implemented and either symptom onset or a positive test result is assumed to result in immediate isolation until the individual is no longer infectious. The bars represent the median estimates and the error bars show the ranges (minima and maxima) across the different infectiousness curves and test positivity curves (when testing was included)

Back to article page